Ellison Institute of Technology

Los Angeles, California 90064

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer, Breast Carcinoma, Breast Tumor, Cancer of Breast, Cancer of Ovary, Cancer of Pancreas, Cancer of Prostate, Cancer of the Breast, Cancer of the Ovary, Cancer of the Pancreas, Cancer of the Prostate

Studies at this site

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer — Recruiting now
• NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors — Stopped early